
Sanjay Mittal
About Sanjay Mittal
Data last updated:
Sanjay Mittal has 9 years in corporate governance. Holds Designated Partner and Director roles. Currently with 2 companies, including Indo Safe Healthcare Llp and Indo Safe Pharma Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations. The largest current company by reported revenue is Indo Safe Pharma Private Limited at ₹3.12 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 21 Aug 2017 | 2017 | ₹3.12 Cr (FY 2025) | Active | |
| Designated Partner | 18 Aug 2025 | 2025 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Mittal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Mittal
Sanjay Mittal has 9 years in corporate governance. Holds Designated Partner and Director roles. Currently with 2 companies, including Indo Safe Healthcare Llp and Indo Safe Pharma Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations. The largest current company by reported revenue is Indo Safe Pharma Private Limited at ₹3.12 Cr (FY 2025).
Sanjay Mittal is associated with 2 companies as Designated Partner and Director, including Indo Safe Pharma Private Limited (₹3.12 Cr), Indo Safe Healthcare Llp.
Sanjay Mittal has expertise in Healthcare, General Business.
Sanjay Mittal has 9 years in corporate governance.
By reported revenue, the largest current company of Sanjay Mittal is Indo Safe Pharma Private Limited, with revenue of ₹3.12 Cr (FY 2025).
Sanjay Mittal currently holds positions at 2 companies: Indo Safe Pharma Private Limited (₹3.12 Cr), Indo Safe Healthcare Llp.